Adiposity and cancer risk: new mechanistic insights from epidemiology
Open accessThe DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
Abstract
Excess body adiposity, commonly expressed as body mass index (BMI), is a risk factor for many common adult cancers. Over the past decade, epidemiological data have shown that adiposity-cancer risk associations are specific for gender, site, geographical population, histological subtype and molecular phenotype. The biological mechanisms underpinning these associations are incompletely understood but need to take account of the specificities observed in epidemiology to better inform future prevention strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Systematic reviews on insulin-like growth factor or adiposity and cancer risk took laboratory, animal, and human evidence into account to judge the plausibility of different mechanisms [40,101].”
From COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology (2019) · cites this paper as [101]
In the citing paper
“based on epidemiological and other evidence, obesity probably increases the risk of several cancers [101,103]”
From COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology (2019) · cites this paper as [101]
In the citing paper
“Epidemiology studies have provided evidence for an association between obesity-related metabolic and inflammatory factors, including changes in insulin-like growth factor 1 signaling, adipokines, sex hormones, and systemic inflammation, and CRC risk.80”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [80]
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Genetics of Food Intake Self-Regulation in Childhood: Literature Review and Research Opportunities
Faith, M. S., Carnell, S., & Kral, T. V. E. (2013) · Human Heredity · doi:10.1159/000353879 · Cited by 7,601
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Self-citationAdipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625
Functional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Cited by
Body Fatness and Cancer — Viewpoint of the IARC Working Group
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Grosse, Y., Bianchini, F., & Straif, K. (2016) · New England Journal of Medicine · doi:10.1056/nejmsr1606602 · Cited by 3,596
Microenvironmental regulation of tumour angiogenesis
De Palma, M., Biziato, D., & Petrova, T. V. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.51 · Cited by 1,847
Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease
Manson, J. E., Cook, N. R., Lee, I.-M., Christen, W., Bassuk, S. S., Mora, S., Gibson, H., Gordon, D., Copeland, T., D’Agostino, D., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1809944 · Cited by 1,615
Obesity and cancer risk: Emerging biological mechanisms and perspectives
Avgerinos, K. I., Spyrou, N., Mantzoros, C. S., & Dalamaga, M. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.001 · Cited by 1,567
“The stroma of tumors containsmesenchymal cells (MSCs) that serve as important progenitor cells which, in turn, play an important role in carcinogenesis [37].”
BackgroundInfluentialKey steps for effective breast cancer prevention
Britt, K. L., Cuzick, J., & Phillips, K.-A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0266-x · Cited by 992
Picon‐Ruiz, M., Morata‐Tarifa, C., Valle‐Goffin, J. J., Friedman, E. R., & Slingerland, J. M. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21405 · Cited by 893
Early Detection of Pancreatic Cancer: Opportunities and Challenges
Singhi, A. D., Koay, E. J., Chari, S. T., & Maitra, A. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.259 · Cited by 841
Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer
Song, M., Chan, A. T., & Sun, J. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.06.048 · Cited by 752
Makker, V., MacKay, H., Ray-Coquard, I., Levine, D. A., Westin, S. N., Aoki, D., & Oaknin, A. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00324-8 · Cited by 674
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
Pati, S., Irfan, W., Jameel, A., Ahmed, S., & Shahid, R. K. (2023) · Cancers · doi:10.3390/cancers15020485 · Cited by 677
“The third part of the mechanism relates to the proinflammatory environment cultivated by the altered secretion of many adipokines (polypeptide hormones) by adipose tissue, specifically increased levels of leptin, which is a potent inflammatory, proliferative, and antiapoptotic agent [52,57].”
BackgroundInfluentialAddressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment
Onstad, M. A., Schmandt, R. E., & Lu, K. H. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.4638 · Cited by 643
Carreras-Torres, R., Johansson, M., Haycock, P. C., Wade, K. H., Relton, C. L., Martin, R. M., Davey Smith, G., Albanes, D., Aldrich, M. C., Andrew, A., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0177875 · Cited by 662
Metabolic reprogramming of natural killer cells in obesity limits antitumor responses
Michelet, X., Dyck, L., Hogan, A., Loftus, R. M., Duquette, D., Wei, K., Beyaz, S., Tavakkoli, A., Foley, C., Donnelly, R., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0251-7 · Cited by 621
Global patterns in excess body weight and the associated cancer burden
Sung, H., Siegel, R. L., Torre, L. A., Pearson‐Stuttard, J., Islami, F., Fedewa, S. A., Goding Sauer, A., Shuval, K., Gapstur, S. M., Jacobs, E. J., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21499 · Cited by 548
Dekkers, O. M., Vandenbroucke, J. P., Cevallos, M., Renehan, A. G., Altman, D. G., & Egger, M. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002742 · Cited by 525
Self-citationDiabetes, pancreatogenic diabetes, and pancreatic cancer
Andersen, D. K., Korc, M., Petersen, G. M., Eibl, G., Li, D., Rickels, M. R., Chari, S. T., & Abbruzzese, J. L. (2017) · Diabetes · doi:10.2337/db16-1477 · Cited by 516
“There is strong evidence that obesity is associated with an increased risk of cancer, including pancreatic cancer (23).”
BackgroundDamage-associated molecular patterns in cancer: a double-edged sword
Hernandez, C., Huebener, P., & Schwabe, R. F. (2016) · Oncogene · doi:10.1038/onc.2016.104 · Cited by 480
Cancer as a Matter of Fat: The Crosstalk between Adipose Tissue and Tumors
Lengyel, E., Makowski, L., DiGiovanni, J., & Kolonin, M. G. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2018.03.004 · Cited by 424
“For example, while obesity is associated with an increased risk of postmenopausal breast cancer, menopausal status is not a factor in the negative effects of obesity on prognosis [8].”
BackgroundSteele, C. B., Thomas, C. C., Henley, S. J., Massetti, G. M., Galuska, D. A., Agurs-Collins, T., Puckett, M., & Richardson, L. C. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6639e1 · Cited by 408
“However, the population effect of weight loss interventions on cancer risk might not be observable for at least a decade (4).”
BackgroundFreisling, H., Viallon, V., Lennon, H., Bagnardi, V., Ricci, C., Butterworth, A. S., Sweeting, M., Muller, D., Romieu, I., Bazelle, P., et al. (2020) · BMC Medicine · doi:10.1186/s12916-019-1474-7 · Cited by 376
Allen, A. M., Hicks, S. B., Mara, K. C., Larson, J. J., & Therneau, T. M. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.018 · Cited by 312
“The proposed candidate mechanisms for the adiposity-cancer link include altered sex hormone metabolism, increased insulin levels and bioavailability of insulin-like growth factor 1, adipokine pathophysiology and systemic inflammation(19, 20).”
BackgroundObesity and cancer: An update of the global impact
Arnold, M., Leitzmann, M., Freisling, H., Bray, F., Romieu, I., Renehan, A., & Soerjomataram, I. (2016) · Cancer Epidemiology · doi:10.1016/j.canep.2016.01.003 · Cited by 300
“Given the volume of epidemiological evidence linking excess adiposity with increased incidence of several adult cancer types, and the plausible biological mechanisms underpinning these associations [42], it is reasonable to speculate that excess weight also has an adverse effect on patients who develop ‘obesity-relate…”
BackgroundSelf-citationWen, Y.-A., Xing, X., Harris, J. W., Zaytseva, Y. Y., Mitov, M. I., Napier, D. L., Weiss, H. L., Mark Evers, B., & Gao, T. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.21 · Cited by 291
“known to secrete proinflammatory cytokines to promote tumorigenesis.(10,12) Here, we uncover a novel role of adipocytes”
BackgroundObesity, Type 2 Diabetes, and Cancer Risk
Scully, T., Ettela, A., LeRoith, D., & Gallagher, E. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.615375 · Cited by 256
Carreras-Torres, R., Johansson, M., Gaborieau, V., Haycock, P. C., Wade, K. H., Relton, C. L., Martin, R. M., Davey Smith, G., & Brennan, P. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx012 · Cited by 263
“in terms of risk and deserves further investigation (43).”
BackgroundVeronese, N., Facchini, S., Stubbs, B., Luchini, C., Solmi, M., Manzato, E., Sergi, G., Maggi, S., Cosco, T., & Fontana, L. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.11.017 · Cited by 251
Pipitone, R. M., Ciccioli, C., Infantino, G., La Mantia, C., Parisi, S., Tulone, A., Pennisi, G., Grimaudo, S., & Petta, S. (2023) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188221145549 · Cited by 233
Adipokines: masterminds of metabolic inflammation
Tilg, H., Ianiro, G., Gasbarrini, A., & Adolph, T. E. (2025) · Nature Reviews Immunology · doi:10.1038/s41577-024-01103-8 · Cited by 192
“Obesity is a major risk factor for malignancy across organ systems 181,182 and chronic inflammation is a hallmark of solid malignancies 183 .”
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?
Klil-Drori, A. J., Azoulay, L., & Pollak, M. N. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.120 · Cited by 210
Obesity and Endometrial Cancer
Shaw, E., Farris, M., McNeil, J., & Friedenreich, C. (2016) · Recent Results in Cancer Research · doi:10.1007/978-3-319-42542-9_7 · Cited by 199
Adiposity and gastrointestinal cancers: epidemiology, mechanisms and future directions
Murphy, N., Jenab, M., & Gunter, M. J. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0038-1 · Cited by 194
Obesity and Cancer: Evidence, Impact, and Future Directions
Colditz, G. A., & Peterson, L. L. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.277376 · Cited by 187
Sung, J. J. Y., Chiu, H.-M., Jung, K.-W., Jun, J. K., Sekiguchi, M., Matsuda, T., & Kyaw, M. H. (2019) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000133 · Cited by 169
Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine
Ogino, S., Nowak, J. A., Hamada, T., Phipps, A. I., Peters, U., Milner Jr, D. A., Giovannucci, E. L., Nishihara, R., Giannakis, M., Garrett, W. S., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315537 · Cited by 169
Louwen, F., Ritter, A., Kreis, N. N., & Yuan, J. (2018) · Obesity Reviews · doi:10.1111/obr.12679 · Cited by 160
Fritz, J., Bjørge, T., Nagel, G., Manjer, J., Engeland, A., Häggström, C., Concin, H., Teleka, S., Tretli, S., Gylling, B., et al. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyz053 · Cited by 174
Body Mass Index, Waist Circumference, Diabetes, and Risk of Liver Cancer for U.S. Adults
Campbell, P. T., Newton, C. C., Freedman, N. D., Koshiol, J., Alavanja, M. C., Beane Freeman, L. E., Buring, J. E., Chan, A. T., Chong, D. Q., Datta, M., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0787 · Cited by 149
“Excess adipose tissue in the liver, in turn, may lead to tissue remodeling (including the development of fibrosis and cirrhosis), increased localized inflammation, and insulin insensitivity/resistance (31, 32).”
BackgroundSelf-citationCharacterization of the salivary microbiome in people with obesity
Wu, Y., Chi, X., Zhang, Q., Chen, F., & Deng, X. (2018) · PeerJ · doi:10.7717/peerj.4458 · Cited by 149
The Obesity Paradox in Cancer: Epidemiologic Insights and Perspectives
Lee, D. H., & Giovannucci, E. L. (2019) · Current Nutrition Reports · doi:10.1007/s13668-019-00280-6 · Cited by 167
Potential and Therapeutic Roles of Diosmin in Human Diseases
Huwait, E. A., & Mobashir, M. (2022) · Biomedicines · doi:10.3390/biomedicines10051076 · Cited by 174
Zhan, H., Zhou, B., Cheng, Y., Xu, J., Wang, L., Zhang, G., & Hu, S. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.01.041 · Cited by 171
Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer
Eibl, G., Cruz-Monserrate, Z., Korc, M., Petrov, M. S., Goodarzi, M. O., Fisher, W. E., Habtezion, A., Lugea, A., Pandol, S. J., Hart, P. A., et al. (2018) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2017.07.005 · Cited by 139
Freisling, H., Arnold, M., Soerjomataram, I., O'Doherty, M. G., Ordóñez-Mena, J. M., Bamia, C., Kampman, E., Leitzmann, M., Romieu, I., Kee, F., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.106 · Cited by 145
“However, associations with BMI appear to be unrelated to receptor status in postmenopausal women who have never used HT (Renehan et al , 2015).”
BackgroundInfluentialTrajectory of body shape across the lifespan and cancer risk
Song, M., Willett, W. C., Hu, F. B., Spiegelman, D., Must, A., Wu, K., Chan, A. T., & Giovannucci, E. L. (2016) · International Journal of Cancer · doi:10.1002/ijc.29981 · Cited by 141
“Some of the potential mechanisms through which obesity affects cancer development include hyperinsulinemia, excess activation of the insulin-like growth factor (IGF) axis, dysregulated production of sex hormones and adipokines, and chronic low-grade inflammation.(5) Other more organ-specific mechanisms linking obesity…”
BackgroundThe Plausibility of Obesity Paradox in Cancer—Point
Park, Y., Peterson, L. L., & Colditz, G. A. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3043 · Cited by 142
“(IGFs) and sex hormones pathways (4,5), the harmful effect of body fatness on cancer etiology is clear.”
BackgroundOxygenation of adipose tissue: A human perspective
Lempesis, I. G., van Meijel, R. L. J., Manolopoulos, K. N., & Goossens, G. H. (2019) · Acta Physiologica · doi:10.1111/apha.13298 · Cited by 142
Metabolic obesity phenotypes and risk of breast cancer in postmenopausal women
Kabat, G. C., Kim, M. Y., Lee, J. S., Ho, G. Y., Going, S. B., Beebe-Dimmer, J., Manson, J. E., Chlebowski, R. T., & Rohan, T. E. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0495 · Cited by 136
“Prolonged hyperinsulinemiamay additionally result in increased levels of free or bioactive IGF-1, which also promotes signaling pathways favoring tumor development (25).”
BackgroundProspective analysis of circulating metabolites and breast cancer in EPIC
His, M., Viallon, V., Dossus, L., Gicquiau, A., Achaintre, D., Scalbert, A., Ferrari, P., Romieu, I., Onland‐Moret, N. C., Weiderpass, E., et al. (2019) · BMC Medicine · doi:10.1186/s12916-019-1408-4 · Cited by 140
Overall and Central Obesity and Risk of Lung Cancer: A Pooled Analysis
Yu, D., Zheng, W., Johansson, M., Lan, Q., Park, Y., White, E., Matthews, C. E., Sawada, N., Gao, Y.-T., Robien, K., et al. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx286 · Cited by 125
Qureshi, R., Picon-Ruiz, M., Aurrekoetxea-Rodriguez, I., Nunes de Paiva, V., D’Amico, M., Yoon, H., Radhakrishnan, R., Morata-Tarifa, C., Ince, T., Lippman, M. E., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.05.008 · Cited by 127
Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies†
AlAshqar, A., Reschke, L. D., Kirschen, G. W., & Borahay, M. A. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab054 · Cited by 136
“In particular, visceral adipose tissue is the major contributor to obesity-induced inflammation and insulin resistance [126].”
BackgroundInfluentialSasaki, A., Nagatake, T., Egami, R., Gu, G., Takigawa, I., Ikeda, W., Nakatani, T., Kunisawa, J., & Fujita, Y. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.104 · Cited by 124
“…progression, e.g., oxidative stress, chronic inflammation, dysbiosis, and hormonal alterations (Bianchini et al., 2002; Donohoe et al., 2017; Font-Burgada et al., 2016; Hopkins et al., 2016; Khandekar et al., 2011; Lauby-Secretan et al., 2016; Poloz and Stambolic, 2015; Renehan et al., 2015).”
MacKintosh, M. L., Derbyshire, A. E., McVey, R. J., Bolton, J., Nickkho‐Amiry, M., Higgins, C. L., Kamieniorz, M., Pemberton, P. W., Kirmani, B. H., Ahmed, B., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31913 · Cited by 135
“Despite these epidemiological associations, the mechanisms linking obesity and EC are incompletely understood, but are likely to include the proliferative effects of excess estrogen unopposed by progesterone in noncycling premenopausal and postmenopausal endometrium, insulin resistance and the proinflammatory state ob…”
BackgroundSelf-citationTerry, A. R., Nogueira, V., Rho, H., Ramakrishnan, G., Li, J., Kang, S., Pathmasiri, K. C., Bhat, S. A., Jiang, L., Kuchay, S., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.09.012 · Cited by 122
The Role of Adipokines in Tumor Progression and Its Association with Obesity
Kim, J., Kim, J. H., & Lee, Y. J. (2024) · Biomedicines · doi:10.3390/biomedicines12010097 · Cited by 131
“Adiponectin is the most abundant adipokine secreted mainly from visceral adipose tissue [12].”
BackgroundInfluentialDiabetes and Colorectal Cancer Risk: Clinical and Therapeutic Implications
Yu, G., Li, S.-F., Wei, R., & Jiang, Z. (2022) · Journal of Diabetes Research · doi:10.1155/2022/1747326 · Cited by 123
“Adiponectininduced activation of the AMPK pathway was shown to downregulate the PI3K/Akt pathway, which plays a vital role in the process of colorectal tumorigenesis promoted by diabetes [71].”
BackgroundRuze, R., Song, J., Yin, X., Chen, Y., Xu, R., Wang, C., & Zhao, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01376-w · Cited by 125
Critical role for arginase 2 in obesity-associated pancreatic cancer
Zaytouni, T., Tsai, P.-Y., Hitchcock, D. S., DuBois, C. D., Freinkman, E., Lin, L., Morales‐Oyarvide, V., Lenehan, P. J., Wolpin, B. M., Mino-Kenudson, M. A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00331-y · Cited by 109
“The crucial role of ARG2 in PDA tumor growth in vivo, but not in vitro, led us to investigate whether candidate metabolites or growth factors that are elevated in obesity 24 (Supplementary Fig.”
BackgroundA Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk
Moore, S. C., Playdon, M. C., Sampson, J. N., Hoover, R. N., Trabert, B. L., Matthews, C. E., & Ziegler, R. G. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx244 · Cited by 119
“Decades of research on steroid hormones, insulin resistance, and inflammation indicate that these factors explain some, but not all, of obesity’s effect on cancer risk (4,5).”
Integration of molecular pathology, epidemiology and social science for global precision medicine
Nishi, A., Milner, D. A., Giovannucci, E. L., Nishihara, R., Tan, A. S. L., Kawachi, I. I., & Ogino, S. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2016.1115346 · Cited by 110
Statins: a role in breast cancer therapy?
Borgquist, S., Bjarnadottir, O., Kimbung, S., & Ahern, T. P. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12806 · Cited by 101
The Impact of the Adipose Organ Plasticity on Inflammation and Cancer Progression
Corrêa, L. H., Cardoso, G. S. H. R., & Magalhães, K. G. (2019) · Cells · doi:10.3390/cells8070662 · Cited by 109
Drilling for Oil: Tumor-Surrounding Adipocytes Fueling Cancer
Attané, C., & Muller, C. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.03.001 · Cited by 97
The ambiguous role of obesity in oncology by promoting cancer but boosting antitumor immunotherapy
Assumpção, J. A. F., Pasquarelli-do-Nascimento, G., Viegas, M. S., Bonamino, M., & Magalhães, K. G. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00796-0 · Cited by 100
Inamura, K., Hamada, T., Bullman, S., Ugai, T., Yachida, S., & Ogino, S. (2022) · Gut · doi:10.1136/gutjnl-2022-327209 · Cited by 100
Naik, A., Monjazeb, A. M., & Decock, J. V. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01940 · Cited by 100
Insulin resistance in patients with cancer: a systematic review and meta-analysis
Màrmol, J. M., Carlsson, M., Raun, S. H., Grand, M. K., Sørensen, J., Lehrskov, L. L., Richter, E. A., Norgaard, O., & Sylow, L. (2023) · Acta Oncologica · doi:10.1080/0284186x.2023.2197124 · Cited by 104
“If obesity was driving the insulin resistance in patients diagnosed with cancer, we would expect insulin resistance to be particularly pronounced for obesity-related cancers, such as colorectal, breast, uterus, ovary, and kidney cancer [50].”
BackgroundObesity and Cancer Metastasis: Molecular and Translational Perspectives
Annett, S., Moore, G., & Robson, T. (2020) · Cancers · doi:10.3390/cancers12123798 · Cited by 99
“In breast cancer, for example, obesity is only associated with an increased incidence of post-menopausal breast cancer, whilst obesity is a risk factor for progression in all breast cancer subtypes [4].”
BackgroundLongitudinal body mass index and cancer risk: a cohort study of 2.6 million Catalan adults
Recalde, M., Pistillo, A., Dávila‐Batista, V., Leitzmann, M. F., Romieu, I., Viallon, V., Freisling, H., & Duarte‐Salles, T. (2023) · Nature Communications · doi:10.1038/s41467-023-39282-y · Cited by 102
Systematic review of Mendelian randomization studies on risk of cancer
Markozannes, G., Kanellopoulou, A., Dimopoulou, O., Kosmidis, D., Zhang, X., Wang, L., Τheodoratou, E., Gill, D., Burgess, S., & Tsilidis, K. K. (2022) · BMC Medicine · doi:10.1186/s12916-022-02246-y · Cited by 106
Larsson, S. C., Spyrou, N., & Mantzoros, C. S. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155326 · Cited by 89
Gender Differences in Obesity-Related Cancers
Argyrakopoulou, G., Dalamaga, Μ., Spyrou, N., & Kokkinos, A. D. (2021) · Current Obesity Reports · doi:10.1007/s13679-021-00426-0 · Cited by 94
KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops
Eibl, G., & Rozengurt, E. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.10.007 · Cited by 85
Current Status and Application of Metformin for Prostate Cancer: A Comprehensive Review
Ahn, H. K., Lee, Y. H., & Koo, K. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228540 · Cited by 94
“As a result, the AMP to ATP ratio is increased, and cells are stressed, which activates AMPK [27,28].”
BackgroundInfluentialImpact of obesity on breast cancer recurrence and minimal residual disease
Ecker, B. L., Lee, J. Y., Sterner, C. J., Solomon, A. C., Pant, D. K., Shen, F., Peraza, J., Vaught, L. A., Mahendra, S., Belka, G. K., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-018-1087-7 · Cited by 89
Tumour–adipose tissue crosstalk: fuelling tumour metastasis by extracellular vesicles
de Lope, L. R., Leaman, O., López, A. A., Hergueta‐Redondo, M., & Peinado, H. (2017) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0485 · Cited by 87
Kelly, S. P., Graubard, B. I., Andreotti, G., Younes, N., Cleary, S. D., & Cook, M. B. (2017) · Journal of the National Cancer Institute · doi:10.1093/jnci/djw225 · Cited by 81
“There is a complex array of biological mechanisms through which obesity may influence prostate carcinogenesis and metastasis, including hyperinsulinemia, elevated insulin-like growth factor (IGF) hormone levels, dysregulation of sex steroid hormones, altered levels of adipokines, and chronic inflammation (3,44).”
BackgroundMicrobiota as a mediator of cancer progression and therapy
Pope, J. L., Tomkovich, S., Yang, Y., & Jobin, C. (2017) · Translational Research · doi:10.1016/j.trsl.2016.07.021 · Cited by 79
Jochem, C., Wallmann-Sperlich, B., & Leitzmann, M. F. (2019) · Current Nutrition Reports · doi:10.1007/s13668-019-0263-4 · Cited by 91
Valdemarin, F., Caffa, I., Persia, A., Cremonini, A. L., Ferrando, L., Tagliafico, L., Tagliafico, A. S., Guijarro, A. I., Carbone, F., Ministrini, S., et al. (2021) · Cancers · doi:10.3390/cancers13164013 · Cited by 83
Associations of Adiposity, Circulating Protein Biomarkers, and Risk of Major Vascular Diseases
Pang, Y., Kartsonaki, C., Lv, J., Fairhurst-Hunter, Z., Millwood, I. Y., Yu, C., Guo, Y., Chen, Y., Bian, Z., Yang, L., et al. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2020.6041 · Cited by 75
Cellular mechanisms linking cancers to obesity
Liu, X., Pedersen, L., & Halberg, N. (2021) · Cell Stress · doi:10.15698/cst2021.05.248 · Cited by 77
Su, Y.-H., Wu, Y., Ann, D. K., Chen, J. L., & Kuo, C. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05576-8 · Cited by 73
“Both central and local fats contribute to a tumor-favorable environment via autocrine or paracrine effects mediated by adipocyte-secreted factors [8, 48].”
BackgroundBMI and weight changes and risk of obesity-related cancers: a pooled European cohort study
Bjørge, T., Häggström, C., Ghaderi, S., Nagel, G., Manjer, J., Tretli, S., Ulmer, H., Harlid, S., Rosendahl, A. H., Lang, A. H., et al. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyz188 · Cited by 84
A Body Shape Index (ABSI), hip index, and risk of cancer in the UK Biobank cohort
Christakoudi, S., Tsilidis, K. K., Εvangelou, Ε., & Ríboli, E. (2021) · Cancer Medicine · doi:10.1002/cam4.4097 · Cited by 77
Tworoger, S. S., & Huang, T. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-42542-9_9 · Cited by 80
Obesity and melanoma: could fat be fueling malignancy?
Clement, E., Lazar, I., Muller, C., & Nieto, L. (2017) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12584 · Cited by 71
“Indeed, obesity increases incidence, progression, death and recurrence after treatment in several cancers (Calle and Kaaks, 2004; Renehan et al., 2015).”
BackgroundInfluentialObesity as risk factor for subtypes of breast cancer: results from a prospective cohort study
Nattenmüller, C. J., Kriegsmann, M., Sookthai, D., Fortner, R. T., Steffen, A., Walter, B., Johnson, T., Kneisel, J., Katzke, V. A., Bergmann, M. M., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4548-6 · Cited by 77
“Relationships between BMI at recruitment and breast cancer risk were evaluated separately among 1) women, who were pre- or perimenopausal at baseline 2) women, who were postmenopausal at baseline and used hormone therapy (HT), and 3) women, who were postmenopausal at baseline and did not use HT, as differential risk a…”
Bandera, E. V., Fay, S. H., Giovannucci, E. L., Leitzmann, M. F., Marklew, R., McTiernan, A., Mullee, A., Romieu, I., Thune, I., Uauy, R. D., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30248 · Cited by 79
“inflammation, oestrogen levels in postmenopausal women, insulin resistance and hyperinsulinemia.(19) Adipose tissue in humans is a structural and thermal buffer, a store of energy in the form of lipid (principally triglycerides), and an active endocrine organ involved in hormonal secretion and metabolism that contribu…”
BackgroundGender Differences in Oxidative Stress in Relation to Cancer Susceptibility and Survival
Allegra, A., Caserta, S., Genovese, S., Pioggia, G., & Gangemi, S. (2023) · Antioxidants · doi:10.3390/antiox12061255 · Cited by 76
“The risks for various cancers, including colon, rectal, gallbladder, kidney, and pancreatic cancers, are associated differently by gender depending on BMI and other somatometric factors [42,43].”
BackgroundLu, B., Li, N., Luo, C., Cai, J., Lu, M., Zhang, Y., Chen, H., & Dai, M. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001619 · Cited by 78
“Therefore, for countries with high burden of CRC, implementationofpopulation-basedCRCscreeningprograms targeting high-risk populationmight be a feasible and effectiveway in reducing the incidence andmortality of CRC.”
BackgroundInfluentialDesmedt, C., Demicheli, R., Fornili, M., Bachir, I., Duca, M., Viglietti, G., Berlière, M., Piccart, M. J., Sotiriou, C. P., Sosnowski, M., et al. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy042 · Cited by 72
“Several biological mechanisms have been proposed to explain this adiposity–breast cancer connection, related mainly to hormonal status (estrogens and adipokines), insulin resistance, inflammation, and neo-angiogenesis (16,17).”
BackgroundObesity and the Risk of Gastrointestinal Cancers
Karczewski, J., Krasińska, B., Staszewski, R., Popławska, E., Gulczynska-Elhadi, K., & Dobrowolska, A. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05603-9 · Cited by 72
Fortner, R. T., Katzke, V. A., Kuhn, T. E., & Kaaks, R. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-42542-9_3 · Cited by 85
van den Brandt, P. A., Ziegler, R. G., Wang, M., Hou, T., Li, R., Adami, H., Agnoli, C., Bernstein, L., Buring, J. E., Chen, Y., et al. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00688-3 · Cited by 77
The Impact of Obesity on Gallstone Disease, Acute Pancreatitis, and Pancreatic Cancer
Cruz‐Monserrate, Z., Conwell, D. L., & Krishna, S. G. (2016) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.07.010 · Cited by 68
Obesity and Peripheral Artery Disease: Current Evidence and Controversies
Lempesis, I. G., Varrias, D., Sagris, Μ., Attaran, R., Altin, E. S., Bakoyiannis, C., Palaiodimos, L., Dalamaga, Μ., & Kokkinidis, D. G. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00510-7 · Cited by 74
Yan, C., Zhu, M., Ding, Y., Yang, M., Wang, M., Li, G., Ren, C., Huang, T., Yang, W., He, B., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318760 · Cited by 66
Obesity and Cancer Treatment Outcomes: Interpreting the Complex Evidence
Slawinski, C. G. V., Barriuso, J., Guo, H., & Renehan, A. G. (2020) · Clinical Oncology · doi:10.1016/j.clon.2020.05.004 · Cited by 63
Self-citationAlmanza‐Aguilera, E., Cano, A., Gil‐Lespinard, M., Burguera, N., Zamora‐Ros, R., Agudo, A., & Farràs, M. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.08.001 · Cited by 67
“The mechanistic pathways by which obesity is linked to carcinogenesis are not yet fully elucidated; current evidence suggests that several biological mechanisms might explain this association [54 – 56].”
Metadata
- Authors
- Renehan, A. G., Zwahlen, M., & Egger, M.
- Affiliations
- Manchester Academic Health Science Centre (GB)
- University of Bern (CH)
- Corresponding author
- Renehan, Andrew G.
- Venue
- Nature Reviews Cancer
- Published
- 2015-07-24
- Volume
- 15
- Issue
- 8
- Pages
- 484-498
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1685808974
- Cited by
- 654
- References
- 173
- Citations by year
- 2026: 40 · 2025: 57 · 2024: 71 · 2023: 64 · 2022: 55 · 2021: 69 · 2020: 54 · 2019: 58 · 2018: 54 · 2017: 68 · 2016: 56 · 2015: 7
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- green
- boris.unibe.ch
- Licence
- cc-by-nc
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion, cc-by-nc)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- American Institute for Cancer Research
- Cancer Research UK
- Medical Research Council (MR/K006665/1, MC_PC_13042)
- Economic and Social Research Council (ES/F029721/1, ES/J010014/1)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- obesity, adiposity, cancer risk, body mass index, sex differences, tumor location, histological subtypes, molecular phenotypes, biological mechanisms, cancer prevention
- MeSH terms
- Animals, Humans, Inflammation, Neoplasms, Obesity, Risk Factors, Body Mass Index, Incidence, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.